Reuters reveals India unlikely to resume sizable COVID-19 vaccine exports until October
Reuters was first to report that India is unlikely to resume major exports of COVID-19 vaccines until at least October […] The post Reuters reveals India unlikely to resume sizable COVID-19 vaccine exports until October appeared first on Reuters News Agency.
admin
0
45
Reuters was first to report that India is unlikely to resume major exports of COVID-19 vaccines until at least October as it diverts shots for domestic use, a longer-than-expected delay set to worsen supply shortages for the global COVAX vaccine initiative. The news drew strong reaction from across the world and was confirmed by Serum Institute of India, the world’s largest vaccine maker and a key supplier to the COVAX initiative, when it announced late in the day that it hopes to be able to restart deliveries to COVAX and other countries by year end.
The post Reuters reveals India unlikely to resume sizable COVID-19 vaccine exports until October appeared first on Reuters News Agency.
